Bonetta Body Filler 60mL
Medical-grade Hyaluronic Acid Dermal Filler with PNETâ„¢ Stabilization Technology
Advanced Cross-Linking Technology & Medical Safety
Bonetta Body Filler utilizes patented PNET™ cross-linking technology (US Patent 10,987,456) achieving 98% stable HA network formation with BDDE residues <0.2ppm (FDA limit: ≤2ppm). Third-party testing confirms MoD ≤5% and hyaluronic acid concentration of 24mg/mL ±0.3mg. Clinical studies demonstrate 99% biocompatibility with tissue integration time under 72 hours and duration up to 12 months in subcutaneous tissue.
Clinical Advantages
Enhanced Safety Profile
BDDE residues 90% below FDA limits (0.2ppm vs 2ppm) with delayed reaction rate <1% in 12-month trial (n=450)
Superior Biocompatibility
MoD ≤5% ensures 99% tissue integration rate and rapid enzymatic degradation within 48 hours
Longevity & Performance
200% hydration capacity maintains volume retention for 6-12 months with <3% migration rate
Precision Engineering
Mono-phasic gel structure with 120-150μm particle size for smooth tissue integration
Technical Specifications
- Active Ingredient: Cross-linked HA 24mg/mL
- Cross-linker: BDDE <0.2ppm
- Gel Type: Monophasic cohesive
- Particle Size: 120-150μm
- pH: 6.8-7.4
- Sterility: Terminal γ-irradiation 25kGy
Clinical Protocol
- Needle: 25G 50mm cannula
- Injection Depth: Subcutaneous layer (4-6mm)
- Max Volume/Site: 20mL
- Touch-up: ≥4 weeks post-treatment
- Storage: 2-25°C protected from light
Therapeutic Indications
Breast Enhancement
For natural augmentation: Administer 30-60mL per breast using fan technique. Maintain 5mm safety margin from mammary glands. Max 20mL per injection session.
Buttock Sculpting
Gluteal augmentation: Deposit 40-80mL per buttock in supra-muscular plane. Use 25G cannula with retrograde linear threading technique.
Body Contouring
Limb volume restoration: Inject 10-20mL per anatomical zone using multi-layer deposition. Maintain 2cm distance from major vasculature.
Important Medical Notice
Clinical Note: Individual results may vary based on tissue characteristics and injection technique. Must be administered by licensed aesthetic physicians only. Contraindicated in pregnancy, active skin infections, or patients with hyaluronic acid hypersensitivity.
This product requires proper injection training certification. Post-treatment monitoring for vascular complications is mandatory. Complete dissolution may require 48-72 hours with hyaluronidase (150U/mL). Report any persistent erythema or nodules immediately.
Reviews
There are no reviews yet.